• 1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 2. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409

Recent Advances in the Study of Ethyl (6-hydroxy-2-methylpyrimidin-4-yl)acetate (CAS: 159326-53-1) in Chemical Biology and Pharmaceutical Research

Ethyl (6-hydroxy-2-methylpyrimidin-4-yl)acetate (CAS: 159326-53-1) is a pyrimidine derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various biologically active molecules, including antiviral and anticancer agents. Recent studies have explored its structural properties, synthetic pathways, and biological activities, shedding light on its therapeutic potential.

One of the most notable advancements in the study of ethyl (6-hydroxy-2-methylpyrimidin-4-yl)acetate is its role in the development of novel antiviral agents. Researchers have demonstrated that this compound can be efficiently modified to produce derivatives with enhanced activity against RNA viruses, including influenza and coronaviruses. A 2023 study published in the Journal of Medicinal Chemistry highlighted the compound's ability to inhibit viral replication by targeting specific enzymes involved in viral RNA synthesis.

In addition to its antiviral properties, ethyl (6-hydroxy-2-methylpyrimidin-4-yl)acetate has shown promise in cancer research. Recent investigations have revealed that derivatives of this compound exhibit selective cytotoxicity against certain cancer cell lines, particularly those associated with breast and lung cancers. Mechanistic studies suggest that these derivatives induce apoptosis via the mitochondrial pathway, making them attractive candidates for further preclinical development.

The synthetic accessibility of ethyl (6-hydroxy-2-methylpyrimidin-4-yl)acetate has also been a focus of recent research. A 2024 study in Organic & Biomolecular Chemistry reported an optimized, scalable synthesis route for this compound, which significantly improves yield and reduces production costs. This advancement is expected to facilitate its broader application in drug discovery and development.

Despite these promising findings, challenges remain in the clinical translation of ethyl (6-hydroxy-2-methylpyrimidin-4-yl)acetate-based therapeutics. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed through further structural optimization and in vivo studies. Nevertheless, the compound's versatility and demonstrated biological activities position it as a valuable scaffold for future drug discovery efforts.

In conclusion, ethyl (6-hydroxy-2-methylpyrimidin-4-yl)acetate (CAS: 159326-53-1) represents a promising candidate for the development of novel antiviral and anticancer agents. Recent research has elucidated its mechanisms of action, synthetic pathways, and therapeutic potential, paving the way for future investigations. Continued exploration of this compound and its derivatives is likely to yield significant contributions to the fields of chemical biology and pharmaceutical sciences.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)